Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)

Author(s):
Carvajal, R.D.; Piperno-Neumann, S.; Kapiteijn, E.; Chapman, P.B.; Frank, S.; Joshua, A.M.; Piulats, J.M.; Wolter, P.; Cocquyt, V.; Chmielowski, B.; Evans, T.R.J.; Gastaud, L.; Linette, G.; Berking, C.; Schachter, J.; Rodrigues, M.J.; Shoushtari, A.N.; Clemett, D.; Ghiorghiu, D.; Mariani, G.; Spratt, S.; Lovick, S.; Barker, P.; Kilgour, E.; Lai, Z.W.; Schwartz, G.K.; Nathan, P.
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-04-20
Language
English
Is part of
Journal of Clinical Oncology (2018), Vol. 36, no. 12, p. 1232-+
hdl
1887/86625
doi
10.1200/JCO.2017.74.1090